Bristol-myers Squibb Company recalls EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfi
Recalled July 19, 2017 · FDA recall D-0959-2017 · Bristol-myers Squibb
Hazard
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets. · FDA Class I
Units
48,180 bottles
Sold at
Nationwide in the US
Description
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
Product
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
Manufacturer(s)
Bristol-myers Squibb Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →